Literature DB >> 2458361

Expression of apolipoprotein E by cultured vascular smooth muscle cells is controlled by growth state.

R A Majack1, C K Castle, L V Goodman, K H Weisgraber, R W Mahley, E M Shooter, P J Gebicke-Haerter.   

Abstract

Rat vascular smooth muscle cells (SMC) in culture synthesize and secrete a approximately 38,000-Mr protein doublet or triplet that, as previously described (Majack and Bornstein. 1984. J. Cell Biol. 99:1688-1695), rapidly and reversibly accumulates in the SMC culture medium upon addition of heparin. In the present study, we show that this approximately 38,000-Mr heparin-regulated protein is electrophoretically and immunologically identical to apolipoprotein E (apo-E), a major plasma apolipoprotein involved in cholesterol transport. In addition, we show that expression of apo-E by cultured SMC varies according to growth state: while proliferating SMC produced little apo-E and expressed low levels of apo-E mRNA, quiescent SMC produced significantly more apo-E (relative to other proteins) and expressed markedly increased levels of apo-E mRNA. Northern analysis of RNA extracted from aortic tissue revealed that fully differentiated, quiescent SMC contain significant quantities of apo-E mRNA. These data establish aortic SMC as a vascular source for apo-E and suggest new functional roles for this apolipoprotein, possibly unrelated to traditional concepts of lipid metabolism.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2458361      PMCID: PMC2115305          DOI: 10.1083/jcb.107.3.1207

Source DB:  PubMed          Journal:  J Cell Biol        ISSN: 0021-9525            Impact factor:   10.539


  43 in total

1.  Interaction of plasma lipoproteins containing apolipoproteins B and E with heparin and cell surface receptors.

Authors:  R W Mahley; K H Weisgraber; T L Innerarity
Journal:  Biochim Biophys Acta       Date:  1979-10-26

2.  High resolution two-dimensional electrophoresis of proteins.

Authors:  P H O'Farrell
Journal:  J Biol Chem       Date:  1975-05-25       Impact factor: 5.157

3.  Release of low density lipoprotein from its cell surface receptor by sulfated glycosaminoglycans.

Authors:  J L Goldstein; S K Basu; G Y Brunschede; M S Brown
Journal:  Cell       Date:  1976-01       Impact factor: 41.582

4.  Correlation of procollagen mRNA levels in normal and transformed chick embryo fibroblasts with different rates of procollagen synthesis.

Authors:  D W Rowe; R C Moen; J M Davidson; P H Byers; P Bornstein; R D Palmiter
Journal:  Biochemistry       Date:  1978-05-02       Impact factor: 3.162

5.  Human very low density lipoprotein apolipoprotein E isoprotein polymorphism is explained by genetic variation and posttranslational modification.

Authors:  V I Zannis; J L Breslow
Journal:  Biochemistry       Date:  1981-02-17       Impact factor: 3.162

6.  Mouse macrophages synthesize and secrete a protein resembling apolipoprotein E.

Authors:  S K Basu; M S Brown; Y K Ho; R J Havel; J L Goldstein
Journal:  Proc Natl Acad Sci U S A       Date:  1981-12       Impact factor: 11.205

7.  Apolipoprotein E synthesis in human kidney, adrenal gland, and liver.

Authors:  M L Blue; D L Williams; S Zucker; S A Khan; C B Blum
Journal:  Proc Natl Acad Sci U S A       Date:  1983-01       Impact factor: 11.205

8.  Inhibition of vascular smooth muscle cell growth by endothelial cell-derived heparin. Possible role of a platelet endoglycosidase.

Authors:  J J Castellot; L V Favreau; M J Karnovsky; R D Rosenberg
Journal:  J Biol Chem       Date:  1982-10-10       Impact factor: 5.157

9.  Factors controlling the proliferative rate, final cell density, and life span of bovine vascular smooth muscle cells in culture.

Authors:  D Gospodarowicz; K Hirabayashi; L Giguère; J P Tauber
Journal:  J Cell Biol       Date:  1981-06       Impact factor: 10.539

10.  Cultured endothelial cells produce a heparinlike inhibitor of smooth muscle cell growth.

Authors:  J J Castellot; M L Addonizio; R Rosenberg; M J Karnovsky
Journal:  J Cell Biol       Date:  1981-08       Impact factor: 10.539

View more
  17 in total

1.  Involvement of apolipoprotein E in the hematogenous route of herpes simplex virus type 1 to the central nervous system.

Authors:  Javier S Burgos; Carlos Ramirez; Isabel Sastre; María J Bullido; Fernando Valdivieso
Journal:  J Virol       Date:  2002-12       Impact factor: 5.103

2.  Proliferating or interleukin 1-activated human vascular smooth muscle cells secrete copious interleukin 6.

Authors:  H Loppnow; P Libby
Journal:  J Clin Invest       Date:  1990-03       Impact factor: 14.808

3.  Generation of mice carrying a mutant apolipoprotein E gene inactivated by gene targeting in embryonic stem cells.

Authors:  J A Piedrahita; S H Zhang; J R Hagaman; P M Oliver; N Maeda
Journal:  Proc Natl Acad Sci U S A       Date:  1992-05-15       Impact factor: 11.205

4.  Heparin inhibits c-fos and c-myc mRNA expression in vascular smooth muscle cells.

Authors:  L A Pukac; J J Castellot; T C Wright; B L Caleb; M J Karnovsky
Journal:  Cell Regul       Date:  1990-04

5.  Increased apolipoprotein E and c-fms gene expression without elevated interleukin 1 or 6 mRNA levels indicates selective activation of macrophage functions in advanced human atheroma.

Authors:  R N Salomon; R Underwood; M V Doyle; A Wang; P Libby
Journal:  Proc Natl Acad Sci U S A       Date:  1992-04-01       Impact factor: 11.205

6.  The relative atherogenicity of VLDL and LDL is dependent on the topographic site.

Authors:  Eline Van Craeyveld; Frank Jacobs; Yingmei Feng; Leen C J Thomassen; Johan A Martens; Joke Lievens; Jan Snoeys; Bart De Geest
Journal:  J Lipid Res       Date:  2010-01-19       Impact factor: 5.922

7.  Induction of fibroblast apolipoprotein E expression during apoptosis, starvation-induced growth arrest and mitosis.

Authors:  Carmel M Quinn; Katarina Kågedal; Alexei Terman; Uri Stroikin; Ulf T Brunk; Wendy Jessup; Brett Garner
Journal:  Biochem J       Date:  2004-03-15       Impact factor: 3.857

Review 8.  Progress toward identification of protease activity involved in proteolysis of apolipoprotein e in human brain.

Authors:  Marcos A Marques; Phillip A Owens; Keith A Crutcher
Journal:  J Mol Neurosci       Date:  2004       Impact factor: 3.444

9.  Apolipoprotein E-related neurotoxicity as a therapeutic target for Alzheimer's disease.

Authors:  Marcos A Marques; Keith A Crutcher
Journal:  J Mol Neurosci       Date:  2003       Impact factor: 3.444

10.  Apolipoprotein E localization in human coronary atherosclerotic plaques by in situ hybridization and immunohistochemistry and comparison with lipoprotein lipase.

Authors:  K D O'Brien; S S Deeb; M Ferguson; T O McDonald; M D Allen; C E Alpers; A Chait
Journal:  Am J Pathol       Date:  1994-03       Impact factor: 4.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.